1 March 2016
Michelson Diagnostics’ Dynamic OCT Imaging Technology reveals changes in Skin Blood Vessels in Real-Time
Maidstone, UK, 26 February 2016 – Michelson Diagnostics, a medical device company focused on applications of multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces data showing that its Dynamic OCT imaging technology is able to visualise in...
27 January 2016
Abzena announces significant licence deal for ThioBridge
Significant licence deal for ThioBridge™ ADC linker technology signed with US biotech partner … Cambridge, UK, 25 January 2016 – Abzena plc (AIM:ABZA), a life sciences group providing services and technologies to enable development and manufacture of...
25 January 2016
Catapult secures 9x cash return with sale of Accutronics
20 January 2016
Catapult Ventures appoints Dr Gareth King as Investment Manager
Catapult Ventures has announced the appointment of Dr Gareth King to its new GM&C Life Sciences Fund where he will be Investment Manager. Dr King joins Catapult from Critical Pharmaceuticals, a Catapult life sciences portfolio company, where he has been CEO for the last four...
19 January 2016
Abzena announces Antitope Consortium receives €1.9m European grant
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders … Cambridge, UK – 18 January 2016 – Abzena plc (AIM:ABZA), a life sciences group providing services and technologies to...
15 January 2016
Philips and Monica Healthcare announce collaboration for innovative fetal monitoring solution
New exclusive co-development agreement to develop new advancements in mother and child care … WHAT: Royal Philips today announced an exclusive global co-development agreement with Monica Healthcare, a leading supplier of abdominal fetal monitoring measurements. The two companies...
1 December 2015
Abzena raises £20m and announces acquisition
Cambridge, UK, 24 November 2015 - Abzena plc (AIM:ABZA, ‘Abzena’ or the ‘Group’), a life sciences group providing services and technologies enabling the development and manufacture of biopharmaceutical products, has conditionally raised £20 million...
29 October 2015
Catapult secures exit from Systems Integration through Management Buy-Out
Catapult Ventures (“Catapult”) today announced that it has sold its stake in Lichfield-based Systems Integration (Trading) Ltd (‘S.I’) to the company’s management team. Catapult invested in S.I in 2009 alongside the directors of the business and...
8 October 2015
Catapult secures 5.2x cash return after successful exit from Oxford Cryosystems through Management Buy-Out
30 September 2015
£45m Life Sciences Fund Launched at Alderley Park
Today, Manchester Science Partnerships (MSP) announced the launch of a new fund, with a first close of £30.7m, to support growing businesses in the region’s life sciences sector. The announcement was made at the BioCap 2015 conference held at Alderley Park Conference...